1 year return (CAGR)
-80.58%
Nabriva Therapeutics AG Exchange (NASDAQ, USD)
NBRV
-
-0.05 (-11.11%)
HealthcareBiotechnology & Medical Research
Loading...
3 year return (CAGR)
-85.64%
5 year return (CAGR)
-77.31%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
1.28M
Price/Sales
0.03
Ent value
17.34M
Price/Book
0.39
Div yield
-
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-19.30%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
No data
Stock price data
| Open | 0.40 |
| Daily high | 0.45 |
| Daily low | 0.40 |
| Daily Volume | 5K |
| 1y analyst estimate | 1.00 |
| Beta | 1.55 |
| EPS (TTM) | -25.41 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| NBRV | S&P500 | |
| Current price drop from All-time high | -99.99% | -10.55% |
| Highest price drop | -100.00% | -56.47% |
| Date of highest drop | 6 Sep 2022 | 9 Mar 2009 |
| Avg drop from high | -75.48% | -10.68% |
| Avg time to new high | 2021 days | 12 days |
| Max time to new high | 2020 days | 1805 days |
News
No items found